Kyung Nam Pharm Co Ltd
KOSDAQ:053950
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kyung Nam Pharm Co Ltd
Total Liabilities & Equity
Kyung Nam Pharm Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
Kyung Nam Pharm Co Ltd
KOSDAQ:053950
|
Total Liabilities & Equity
₩155.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
13%
|
|
|
Yuhan Corp
KRX:000100
|
Total Liabilities & Equity
₩3.2T
|
CAGR 3-Years
9%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Total Liabilities & Equity
₩1.2T
|
CAGR 3-Years
22%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Total Liabilities & Equity
₩2.1T
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Total Liabilities & Equity
₩561.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
12%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Total Liabilities & Equity
₩231.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Kyung Nam Pharm Co Ltd
Glance View
Kyungnam Pharm Co., Ltd. manufactures pharmaceutical products. The company is headquartered in Uiryeong-Gun, Gyeongsangnam-Do. The company went IPO on 2001-11-06. The firm's product portfolio consists of vitamin products, placenta products, health food products and general pharmaceuticals. The firm provides vitamin products under the brand name LEMONA. The company supplies health food products such as lactobacillus products through convenient stores and marts. The placenta products include human placenta related injections and drinks. The general pharmaceuticals include athlete foot therapeutic agents, inflammatory drugs, cold remedies, multi-nutrients and others.
See Also
What is Kyung Nam Pharm Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
155.6B
KRW
Based on the financial report for Dec 31, 2025, Kyung Nam Pharm Co Ltd's Total Liabilities & Equity amounts to 155.6B KRW.
What is Kyung Nam Pharm Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
13%
Over the last year, the Total Liabilities & Equity growth was -7%. The average annual Total Liabilities & Equity growth rates for Kyung Nam Pharm Co Ltd have been 3% over the past three years , 4% over the past five years , and 13% over the past ten years .
